Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).
Fracture Prevention and Osteoporosis Management After Menopause
Ophthalmology Update: New Treatments for Old Conditions
Testosterone for Men – Common Myths and Recent Development
Conversation Strategies for Unfunded Vaccinations
expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis